Two (14%) of the 14 total disrupted glycolytic genes were downregulated: ENO4 and PGK2, and their expression was 2.4× lower in depression groups compared to control groups (LFC = −1.19). The gene discussed is PGK2; the disease is depressive symptom measurement.